Kazmi, Taskeen R.Greear, Emma L.Lavallee, Catherine A.Stump, Michael S.Bankole, Adegbenga A.Hsu, Tsai Ching2022-08-092022-08-092022-08-09Taskeen R. Kazmi, Emma L. Greear, Catherine A. Lavallee, Michael S. Stump, and Adegbenga A. Bankole, “Kikuchi-Fujimoto Disease: A Differential for When It is Not Systemic Lupus Erythematosus,” Case Reports in Rheumatology, vol. 2022, Article ID 7709246, 6 pages, 2022. doi:10.1155/2022/77092462090-6889http://hdl.handle.net/10919/111493<jats:p>Kikuchi-Fujimoto disease (KFD) is a rare and benign disease process that is characterized by fever and lymphadenopathy that was first described in young Japanese women in the early 1970s. Knowledge of KFD is important as it can often mimic other causes of lymphadenopathy including systemic lupus erythematosus (SLE) or malignancies, and this can lead to invasive diagnostic testing and even treatments that can be avoided. The etiology and exact mechanism by which KFD develops is not fully understood at this time, but is thought to be an immune response of T cells and histiocytes to viral or bacterial infections. We present a 35-year-old African-American woman who was referred to the rheumatology clinic by our colleagues in the breast clinic with new onset right axillary lymphadenopathy and abnormal serologic testing with the suspicion of SLE after a malignancy had been ruled out.</jats:p>Pages 1-6application/pdfenCreative Commons Attribution 4.0 InternationalArticle2022-08-09https://doi.org/10.1155/2022/77092462022Bankole, Adegbenga [0000-0001-6464-5367]Greear, Emma [0000-0003-0019-0775]2090-6897